1. Home
  2. DCTH vs TSSI Comparison

DCTH vs TSSI Comparison

Compare DCTH & TSSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • TSSI
  • Stock Information
  • Founded
  • DCTH 1988
  • TSSI 2004
  • Country
  • DCTH United States
  • TSSI United States
  • Employees
  • DCTH N/A
  • TSSI N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • TSSI Professional Services
  • Sector
  • DCTH Health Care
  • TSSI Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • TSSI Nasdaq
  • Market Cap
  • DCTH 630.4M
  • TSSI 520.7M
  • IPO Year
  • DCTH N/A
  • TSSI N/A
  • Fundamental
  • Price
  • DCTH $13.85
  • TSSI $25.61
  • Analyst Decision
  • DCTH Strong Buy
  • TSSI
  • Analyst Count
  • DCTH 4
  • TSSI 0
  • Target Price
  • DCTH $24.00
  • TSSI N/A
  • AVG Volume (30 Days)
  • DCTH 531.5K
  • TSSI 2.8M
  • Earning Date
  • DCTH 08-04-2025
  • TSSI 05-15-2025
  • Dividend Yield
  • DCTH N/A
  • TSSI N/A
  • EPS Growth
  • DCTH N/A
  • TSSI 770.13
  • EPS
  • DCTH N/A
  • TSSI 0.35
  • Revenue
  • DCTH $53,850,000.00
  • TSSI $231,211,000.00
  • Revenue This Year
  • DCTH $155.42
  • TSSI N/A
  • Revenue Next Year
  • DCTH $37.93
  • TSSI N/A
  • P/E Ratio
  • DCTH N/A
  • TSSI $72.96
  • Revenue Growth
  • DCTH 1068.87
  • TSSI 262.87
  • 52 Week Low
  • DCTH $7.17
  • TSSI $1.85
  • 52 Week High
  • DCTH $18.23
  • TSSI $27.04
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 37.03
  • TSSI N/A
  • Support Level
  • DCTH $15.72
  • TSSI N/A
  • Resistance Level
  • DCTH $17.35
  • TSSI N/A
  • Average True Range (ATR)
  • DCTH 0.74
  • TSSI 0.00
  • MACD
  • DCTH -0.40
  • TSSI 0.00
  • Stochastic Oscillator
  • DCTH 2.23
  • TSSI 0.00

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About TSSI TSS Inc. Common Stock

TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: Procurement, Systems Integration, and Facilities Management. It generates the majority of its revenue from the Procurement segment.

Share on Social Networks: